Louis Ferrari
Keine laufenden Positionen mehr
Profil
Louis Ferrari served as the President, Chief Executive Officer & Director at Savient Pharmaceuticals, Inc. from 2012 to 2013.
He holds an MBA from Adelphi University and an undergraduate degree from Arnold & Marie Schwartz College of Pharmacy & Health Science.
Ehemalige bekannte Positionen von Louis Ferrari
| Unternehmen | Position | Ende |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Vorstandsvorsitzender | 20.06.2013 |
Ausbildung von Louis Ferrari
| Adelphi University | Masters Business Admin |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
